RVMDRevolution Medicines, Inc.
$189.76+336% 1Y
$189.76
$42.5152 weeks$216.19
Is the business good?
Watch
1 to watch, 3 without dataMargins compressing. That is the only one of 4 checks this filer's data supports, so take it as a single data point rather than a settled answer.
Margin direction, 3 years−1466.9 ptsderived
Operating margin has narrowed over the past few years, profitability per dollar of sales is eroding.
Where this answer is blind. The F-score rewards improvement, so an already-elite company can score mid-pack.
How good a business is RVMD?
- Share count, year on year
- +12%
Share count, year on year · shareholders own a smaller slice than a year ago
| Year | Operating margin |
|---|---|
| FY2020 | −258% |
| FY2021 | −640% |
| FY2022 | −730% |
| FY2023 | −4207% |
Details›
- Free cash flow, trailing twelve months
- −$1.23B
- Net income, trailing twelve months
- −$1.77B
Margins, capital and share counts from the statements as filed with the SEC; cash conversion is operating cash flow over operating profit after tax.